Showing results (71-80 of 3,813) with videos related to
Sort By:
Pageof 382
Chemotherapy|January 1, 1987
Pharmacokinetics of cinoxacin in elderly patients following repeated oral administrationP C Braga, F Fraschini, F Scaglione, et al.Chemotherapy|January 1, 1986
Evaluation of the immunostimulating activity of erythromycin in manF Fraschini, F Scaglione, F Ferrara, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot studyG Bisagni, G Cocconi, F Scaglione, et al.Chronobiologia|October 1, 1986
Ultradian chronomodulation by melatonin of a Placebo effect upon human killer cell activityP Lissoni, O Marelli, R Mauri, et al.The International Journal of Biological Markers|July 1, 1988
Serum levels of melatonin in cancer patients and their relation to body sizesS Barni, P Lissoni, S Crispino, et al.Journal of Pineal Research|January 15, 2010
Pharmacokinetics of orally administered melatonin in critically ill patientsGiovanni Mistraletti, Giovanni Sabbatini, Martina Taverna, et al.Drugs Under Experimental and Clinical Research|January 1, 1988
Pharmacokinetic profile of cefotetan in different clinical conditionsF Fraschini, F Scaglione, M Mezzetti, et al.The Journal of International Medical Research|July 1, 1988
Comparison of miocamycin versus amoxycillin in lower respiratory tract infections in children. Clinical response and effect on natural killer activityC Agostoni, M Giovannini, F Fraschini, et al.International Journal of Clinical Pharmacology Research|January 1, 1988
Xibornol: multiple dose pharmacokinetics and diffusion in lung, tonsillar tissue and laryngeal mucosaF Scaglione, R Trazzi, A Odero, et al.Life Sciences|January 1, 1993
Primary pharmaco-toxicological evaluation of 2-iodomelatonin, a potent melatonin agonistB Stankov, M Gervasoni, F Scaglione, et al.Pageof 382